These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11905682)

  • 1. Prostate cancer: to screen or not to screen?
    Neal DE; Donovan JL
    Lancet Oncol; 2000 Sep; 1(1):17-24. PubMed ID: 11905682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, management and screening of early localised prostate cancer.
    Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
    Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against.
    Hall RR
    Eur Urol; 1996; 29 Suppl 2():24-6. PubMed ID: 8717457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen testing to screen for prostate cancer.
    Budenholzer BR
    J Fam Pract; 1995 Sep; 41(3):270-8. PubMed ID: 7544400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and early detection for prostate cancer.
    Magoha GA
    East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening: more harm than good?
    Lefevre ML
    Am Fam Physician; 1998 Aug; 58(2):432-8. PubMed ID: 9713397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening: a decision analysis.
    Cantor SB; Spann SJ; Volk RJ; Cardenas MP; Warren MM
    J Fam Pract; 1995 Jul; 41(1):33-41. PubMed ID: 7798064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer. A decision analytic view.
    Krahn MD; Mahoney JE; Eckman MH; Trachtenberg J; Pauker SG; Detsky AS
    JAMA; 1994 Sep; 272(10):773-80. PubMed ID: 7521400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention strategies for prostate cancer.
    Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
    Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
    CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years.
    Postma R; Roobol M; Schröder FH; van der Kwast TH
    Cancer; 2004 Mar; 100(5):968-75. PubMed ID: 14983492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality.
    Labrie F; Cusan L; Gomez JL; Diamond P; Candas B
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2002-13. PubMed ID: 7541800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer.
    Vis AN; van Rhijn BW; Noordzij MA; Schröder FH; van der Kwast TH
    J Pathol; 2002 Jun; 197(2):148-54. PubMed ID: 12015737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
    Roobol MJ; Kranse R; de Koning HJ; Schröder FH
    Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advancement in diagnosis and treatment of prostate cancer--general concepts].
    Akaza H
    Nihon Rinsho; 2005 Feb; 63(2):237-40. PubMed ID: 15714972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?
    Gosselaar C; Roobol MJ; Schröder FH
    BJU Int; 2005 Feb; 95(2):231-7. PubMed ID: 15667646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.